Mark E. Bertels - 04 Mar 2026 Form 4 Insider Report for CORVEL CORP (CRVL)

Reporting relationship
EVP - Risk Management Services
Issuer ticker
CRVL
Reported as of
04 Mar 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Mar 2026, 13:56:31 UTC
Prior SEC filing
20 Nov 2025
Next SEC filing
02 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: Sharon O'Connor For: Mark Bertels

Key filing fact

Mark E. Bertels filed Form 4 for CORVEL CORP (CRVL) on 06 Mar 2026.

Key facts

  • This page summarizes Mark E. Bertels's Form 4 filing for CORVEL CORP (CRVL).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 06 Mar 2026, 13:56.

Change

  • Previous filing in this sequence was filed on 20 Nov 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001921051 Primary reporting owner

Bertels Mark E.

Relationship
EVP - Risk Management Services
Address
5128 APACHE PLUME ROAD, SUITE 400, FORT WORTH
Signature
By: Sharon O'Connor For: Mark Bertels
Signature date
06 Mar 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRVL transaction Derivative

Non-Qualified Stock Option (right to buy)

Award

Transaction value
Shares
+6,000
Change %
Price
$0.000000*
Shares after
6,000
Date
04 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,000
Exercise price
$53.08
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .